The Middle East & Africa pulmonary function testing systems market was valued at US$ 12.86 million in 2022 and is expected to reach US$ 17.48 million by 2028; it is estimated to register a CAGR of 5.2% from 2022 to 2028.
Technological Advancements in Pulmonary Function Testing Systems to Fuel Middle East & Africa Pulmonary Function Testing Systems Market Growth During Forecast Period
Technological advancements have made spirometry much more reliable and relatively simple. Various major companies are manufacturing technology-enabled pulmonary function testing devices. For example, the Datospir Micro C spirometer, developed by Point of Care Diagnostics Pty Ltd, is a revolutionary touch screen instrument with many easy-to-use features that facilitate lung function testing. The new product is a small portable spirometer with the latest technological advances, and the equipment has different configurations intended for use in clinical settings and at home. The new product can also be connected to other devices through Bluetooth technologies and operates with a large number of parameters related to FVC, VC, MVV, and pulse oximetry (SpO2) options. Additionally, top companies are partnering to scale up the diagnosis and treatment of lung diseases. Such devices can help track patients remotely and even conduct telespirometry with comprehensive care management solutions. Thus, the increase in technological advancements is likely to catalyze the growth of the Middle East & Africa pulmonary function testing systems market during the forecast period.
Middle East & Africa Pulmonary Function Testing Systems Market Overview
The UAE, Saudi Arabia, and South Africa are the three major countries in the Middle East & South Africa. Saudi Arabia was the largest market for pulmonary function testing systems in this region in 2022. The market for pulmonary function testing systems in the Middle East & Africa is anticipated to record a CAGR of 5.2% during the forecast period; this growth is driven by the factors such as increasing cases of chronic obstructive pulmonary disease (COPD) in the Middle East. Other major drivers include technological innovations and increasing demand for technologies in Middle Eastern countries, majorly in the UAE, Saudi Arabia, and Qatar.
Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecast to 2028 (US$ Million)
Strategic insights for the Middle East & Africa Pulmonary Function Testing Systems provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Middle East & Africa Pulmonary Function Testing Systems refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.Middle East & Africa Pulmonary Function Testing Systems Strategic Insights
Middle East & Africa Pulmonary Function Testing Systems Report Scope
Report Attribute
Details
Market size in 2022
US$ 12.86 Million
Market Size by 2028
US$ 17.48 Million
Global CAGR (2022 - 2028)
5.2%
Historical Data
2020-2021
Forecast period
2023-2028
Segments Covered
By Type
By Test Type
By Component
By Application
By End User
Regions and Countries Covered
Middle East and Africa
Market leaders and key company profiles
Middle East & Africa Pulmonary Function Testing Systems Regional Insights
Middle East & Africa Pulmonary Function Testing Systems Market Segmentation
The Middle East & Africa pulmonary function testing systems market is segmented on the basis of type, test type, component, application, end user, and country.
Based on type, the Middle East & Africa pulmonary function testing systems market is bifurcated into cart-based PFT systems and stationery PFT systems. The cart-based PFT systems segment held a larger share of the Middle East & Africa pulmonary function testing systems market in 2022.
Based on test type, the Middle East & Africa pulmonary function testing systems market is segmented into spirometry, lung volume, gas exchange testing, maximum voluntary ventilation, oxygen titration test, and others. The spirometry segment held the largest share of the Middle East & Africa pulmonary function testing systems market in 2022.
Based on component, the Middle East & Africa pulmonary function testing systems market is segmented into hardware, software, and services. The hardware segment held the largest share of the Middle East & Africa pulmonary function testing systems market in 2022.
Based on application, the Middle East & Africa pulmonary function testing systems market is segmented into chronic obstructive pulmonary disorder, asthma, chronic shortness of breath, restrictive lung disease, and others. The chronic obstructive pulmonary disorder segment held the largest share of the Middle East & Africa pulmonary function testing systems market in 2022.
Based on end-user, the Middle East & Africa pulmonary function testing systems market is segmented into hospitals, specialty clinics, and diagnostic laboratories. The hospitals segment held the largest share of the Middle East & Africa pulmonary function testing systems market in 2022.
Based on country, the Middle East & Africa pulmonary function testing systems market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the share of the Middle East & Africa pulmonary function testing systems market in 2022.
COSMED Srl, MGC Diagnostics Corp, PulmOne Advanced Medical Devices Ltd, Schiller AG, and Vyaire Medical Inc are the leading companies operating in the Middle East & Africa pulmonary function testing systems market.
The Middle East & Africa Pulmonary Function Testing Systems Market is valued at US$ 12.86 Million in 2022, it is projected to reach US$ 17.48 Million by 2028.
As per our report Middle East & Africa Pulmonary Function Testing Systems Market, the market size is valued at US$ 12.86 Million in 2022, projecting it to reach US$ 17.48 Million by 2028. This translates to a CAGR of approximately 5.2% during the forecast period.
The Middle East & Africa Pulmonary Function Testing Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Pulmonary Function Testing Systems Market report:
The Middle East & Africa Pulmonary Function Testing Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Pulmonary Function Testing Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Pulmonary Function Testing Systems Market value chain can benefit from the information contained in a comprehensive market report.